Effect of glyburide on beta cell responsiveness to glucose in non-insulin-dependent diabetes mellitus.

[1]  H. Lebovitz,et al.  Sulfonylurea Drugs: Mechanism of Antidiabetic Action and Therapeutic Usefulness , 1978, Diabetes Care.

[2]  A. Zeidler,et al.  Glyburide and Glipizide in Treatment of Diabetic Patients With Secondary Failures to Tolazamide or Chlorpropamid , 1987, Diabetes Care.

[3]  G. Grodsky,et al.  Pancreatic action of the sulfonylureas. , 1977, Federation proceedings.

[4]  K. Osei,et al.  Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism. , 1984, The American journal of medicine.

[5]  A. Rajan,et al.  Increased cytosolic calcium. A signal for sulfonylurea-stimulated insulin release from beta cells. , 1987, The Journal of biological chemistry.

[6]  G. Reaven,et al.  Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia. , 1975, The Journal of clinical investigation.

[7]  B H Frank,et al.  Quantitative study of insulin secretion and clearance in normal and obese subjects. , 1988, The Journal of clinical investigation.

[8]  L. Groop,et al.  Different Effects of Glyburide and Glipizide on Insulin Secretion and Hepatic Glucose Production in Normal and NIDDM Subjects , 1987, Diabetes.

[9]  C. Wollheim,et al.  Regulation of insulin release by calcium. , 1981, Physiological reviews.

[10]  S. O’Rahilly,et al.  Pathogenesis of NIDDM--a disease of deficient insulin secretion. , 1988, Bailliere's clinical endocrinology and metabolism.

[11]  J. Halter,et al.  Potentiation of Insulin Secretion to Nonglucose Stimuli in Normal Man by Tolbutamide , 1980, Diabetes.

[12]  G. Reaven,et al.  Effect of Sulfonylurea Treatment on In Vivo Insulin Secretion and Action in Patients With Non-insulin-dependent Diabetes Mellitus , 1982, Diabetes.

[13]  L. Groop,et al.  Effect of Glyburide on Glycemic Control, Insulin Requirement, and Glucose Metabolism in Insulin-Treated Diabetic Patients , 1987, Diabetes.

[14]  L. Groop,et al.  Comparison of Pharmacokinetics, Metabolic Effects and Mechanisms of Action of Glyburide and Glipizide During Long-Term Treatment , 1987, Diabetes Care.

[15]  G. Reaven,et al.  Glyburide in non-insulin-dependent diabetes. Its therapeutic effect in patients with disease poorly controlled by insulin alone. , 1985, Archives of internal medicine.

[16]  J. A. Scarlett,et al.  Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. , 1981, The Journal of clinical investigation.

[17]  Stephen J. H. Ashcroft,et al.  Glucose induces closure of single potassium channels in isolated rat pancreatic β-cells , 1984, Nature.

[18]  A. Lazarow,et al.  Immunoassay of Insulin: Two Antibody System: Plasma Insulin Levels of Normal, Subdiabetic and Diabetic Rats , 1963, Diabetes.

[19]  J. Olefsky.  Decreased insulin binding to adipocytes and circulating monocytes from obese subjects. , 1976, The Journal of clinical investigation.

[20]  Bruce H. Frank,et al.  Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. , 1986, The Journal of clinical investigation.

[21]  K. Polonsky,et al.  Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. , 1988, The New England journal of medicine.

[22]  P. Casner.  Insulin‐glyburide combination therapy for non‐insulin‐dependent diabetes mellitus: A long‐term double‐blind, placebo‐controlled trial , 1988, Clinical pharmacology and therapeutics.

[23]  S. Hamilton,et al.  Characterization of the sulfonylurea receptor on beta cell membranes. , 1988, The Journal of biological chemistry.

[24]  J. Halter,et al.  The Effect of Chronic Sulfonylurea Therapy on Hepatic Glucose Production in Non-insulin-dependent Diabetes , 1982, Diabetes.

[25]  E. Matthews,et al.  The control of 86Rb efflux from rat isolated pancreatic islets by the sulphonylureas tolbutamide and glibenclamide , 1984, British journal of pharmacology.

[26]  I. Testa,et al.  Erythrocyte Insulin Receptors in Non-insulin-dependent Diabetes Mellitus , 1980, Diabetes.

[27]  M. Lazdunski,et al.  The receptor for antidiabetic sulfonylureas controls the activity of the ATP-modulated K+ channel in insulin-secreting cells. , 1987, The Journal of biological chemistry.

[28]  M. Mcdaniel,et al.  A metabolite-regulated potassium channel in rat pancreatic B cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[29]  E. Cauter,et al.  Estimating false-positive and false-negative errors in analyses of hormonal pulsatility , 1988 .

[30]  K. Polonsky,et al.  Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus. , 1989, The Journal of clinical endocrinology and metabolism.

[31]  H. Kuzuya,et al.  Characterization of Seven C-peptide Antisera , 1978, Diabetes.

[32]  S. Efendić,et al.  Glyburide Decreases Insulin Requirement, Increases (β-Cell Response to Mixed Meal, and Does Not Affect Insulin Sensitivity: Effects of Short- and Long-Term Combined Treatment in Secondary Failure to Sulfonylurea , 1987, Diabetes Care.

[33]  K. Polonsky,et al.  Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. , 1988, The Journal of clinical investigation.

[34]  E. Cerasi,et al.  Effect of two sulphonylureas on the dose kinetics of glucose-induced insulin release in normal and diabetic subjects. , 1979, Acta endocrinologica.

[35]  S. Berson,et al.  Comparison of Plasma Insulin Levels Following Administration of Tolbutamide and Glucose , 1960, Diabetes.

[36]  B. Draznin,et al.  Glyburide increases cytosolic-free calcium concentrations in normal rat pancreatic islet cells. , 1988, Metabolism: clinical and experimental.

[37]  K. Polonsky,et al.  C-Peptide as a Measure of the Secretion and Hepatic Extraction of Insulin: Pitfalls and Limitations , 1984, Diabetes.

[38]  J. A. Scarlett,et al.  The Acute and Chronic Effects of Sulfonylurea Therapy in Type II Diabetic Subjects , 1984, Diabetes.

[39]  J. Henquin.  D-Glucose inhibits potassium efflux from pancreatic islet cells , 1978, Nature.